Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-17-011044
Filing Date
2017-10-27
Accepted
2017-10-27 17:49:12
Documents
1
Period of Report
2017-10-16

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f3101617schreiber_immudyne.html 3  
1 OWNERSHIP DOCUMENT f3101617schreiber_immudyne.xml 3 5637
  Complete submission text file 0001213900-17-011044.txt   7084
Mailing Address 50 SPRING MEADOW ROAD MT. KISCO NY 10549
Business Address 50 SPRING MEADOW ROAD MT. KISCO NY 10549 (914) 244-1777
Immudyne, Inc. (Issuer) CIK: 0000948320 (see all company filings)

EIN.: 760238453 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address 53 CALLE PALMERAS SUITE 802 SAN JUAN PR 00901
Business Address
Schreiber Justin (Reporting) CIK: 0001720512 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-55857 | Film No.: 171160353